Literature DB >> 15459013

Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Nobuo Kanazawa1, Ikuo Okafuji, Naotomo Kambe, Ryuta Nishikomori, Mami Nakata-Hizume, Sonoko Nagai, Akihiko Fuji, Takenosuke Yuasa, Akira Manki, Yoshihiko Sakurai, Mitsuru Nakajima, Hiroko Kobayashi, Ikuma Fujiwara, Hiroyuki Tsutsumi, Atsushi Utani, Chikako Nishigori, Toshio Heike, Tatsutoshi Nakahata, Yoshiki Miyachi.   

Abstract

Early-onset sarcoidosis (EOS) and inheritable Blau syndrome (BS) share characteristic clinical features of juvenile-onset systemic granulomatosis syndrome that mainly affects skin, joints, and eyes. However, no direct evidence has been shown for the possible common origin of these 2 diseases. Recent discovery of CARD15 mutations in BS families encouraged us to investigate similar CARD15 mutations in EOS patients. Among 10 EOS cases retrospectively collected in Japan, heterozygous missense mutations were found in 9 cases; 4 showed a 1000C>T (R334W in amino acid change) that has been reported in BS, 4 showed novel 1487A>T (H496L), 1538T>C (M513T), 1813A>C (T605P), and 2010C>A (N670K), and 1 case showed double 1146C>G (D382E)/1834G>A (A612T) mutations on different alleles. All 6 of these variants of CARD15 showed increased basal nuclear factor (NF)-kappaB activity. These findings indicate that the majority of EOS and BS cases share the common genetic etiology of CARD15 mutations that cause constitutive NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459013     DOI: 10.1182/blood-2004-07-2972

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  153 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

2.  A novel motif in the Crohn's disease susceptibility protein, NOD2, allows TRAF4 to down-regulate innate immune responses.

Authors:  Jill M Marinis; Craig R Homer; Christine McDonald; Derek W Abbott
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

3.  A novel aminosaccharide compound blocks immune responses by Toll-like receptors and nucleotide-binding domain, leucine-rich repeat proteins.

Authors:  Kyoung-Hee Lee; Yuen-Joyce Liu; Amlan Biswas; Chikako Ogawa; Koichi S Kobayashi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

4.  NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders.

Authors:  K Packwood; E Drewe; E Staples; D Webster; T Witte; J Litzman; W Egner; R Sargur; W Sewell; E Lopez-Granados; S L Seneviratne; R J Powell; B L Ferry; H M Chapel
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 5.  Neutrophilic dermatoses and autoinflammatory diseases with skin involvement--innate immune disorders.

Authors:  Alexander A Navarini; Takashi K Satoh; Lars E French
Journal:  Semin Immunopathol       Date:  2015-11-30       Impact factor: 9.623

6.  Somatic NOD2 mosaicism in Blau syndrome.

Authors:  Jaime de Inocencio; Anna Mensa-Vilaro; Pilar Tejada-Palacios; Eugenia Enriquez-Merayo; Eva González-Roca; Giuliana Magri; Estibaliz Ruiz-Ortiz; Andrea Cerutti; Jordi Yagüe; Juan I Aróstegui
Journal:  J Allergy Clin Immunol       Date:  2015-02-25       Impact factor: 10.793

Review 7.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.

Authors:  Kalpana Manthiram; Qing Zhou; Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

8.  A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways.

Authors:  Neil Warner; Aaron Burberry; Luigi Franchi; Yun-Gi Kim; Christine McDonald; Maureen A Sartor; Gabriel Núñez
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

Review 9.  Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.

Authors:  Raphaela Goldbach-Mansky; Daniel L Kastner
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

10.  Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation.

Authors:  Noemí Marina-García; Luigi Franchi; Yun-Gi Kim; Yonjun Hu; David E Smith; Geert-Jan Boons; Gabriel Núñez
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.